Genmab A/S (GMAB)
30.24
+0.71
(+2.40%)
USD |
NASDAQ |
May 15, 15:55
Genmab Total Return Price: 30.24 for May 15, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 14, 2024 | 29.53 |
| May 13, 2024 | 29.16 |
| May 10, 2024 | 28.84 |
| May 09, 2024 | 28.81 |
| May 08, 2024 | 28.80 |
| May 07, 2024 | 29.29 |
| May 06, 2024 | 29.03 |
| May 03, 2024 | 29.72 |
| May 02, 2024 | 27.72 |
| May 01, 2024 | 28.75 |
| April 30, 2024 | 27.69 |
| April 29, 2024 | 28.57 |
| April 26, 2024 | 28.15 |
| April 25, 2024 | 27.46 |
| April 24, 2024 | 28.47 |
| April 23, 2024 | 28.56 |
| April 22, 2024 | 28.97 |
| April 19, 2024 | 28.70 |
| April 18, 2024 | 28.33 |
| April 17, 2024 | 28.53 |
| April 16, 2024 | 29.43 |
| April 15, 2024 | 29.51 |
| April 12, 2024 | 29.26 |
| April 11, 2024 | 29.74 |
| April 10, 2024 | 29.95 |
| Date | Value |
|---|---|
| April 09, 2024 | 29.97 |
| April 08, 2024 | 29.86 |
| April 05, 2024 | 29.76 |
| April 04, 2024 | 29.65 |
| April 03, 2024 | 29.30 |
| April 02, 2024 | 29.96 |
| April 01, 2024 | 30.27 |
| March 28, 2024 | 29.91 |
| March 27, 2024 | 30.63 |
| March 26, 2024 | 30.83 |
| March 25, 2024 | 29.98 |
| March 22, 2024 | 29.92 |
| March 21, 2024 | 29.56 |
| March 20, 2024 | 29.44 |
| March 19, 2024 | 29.64 |
| March 18, 2024 | 29.69 |
| March 15, 2024 | 29.94 |
| March 14, 2024 | 30.30 |
| March 13, 2024 | 31.34 |
| March 12, 2024 | 31.43 |
| March 11, 2024 | 31.68 |
| March 08, 2024 | 30.30 |
| March 07, 2024 | 29.41 |
| March 06, 2024 | 28.86 |
| March 05, 2024 | 28.75 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
16.71
Minimum
May 15 2019
48.72
Maximum
Sep 03 2021
33.53
Average
35.26
Median
Jul 28 2020
Total Return Price Benchmarks
| Ascendis Pharma A/S | 123.81 |
| Novo Nordisk A/S | 134.65 |
| Galecto Inc | 0.6229 |
| Evaxion Biotech AS | 3.78 |
| IO Biotech Inc | 1.415 |